Acetaminophen (paracetamol) – Exposure, regulatory issues and current litigation
This paper offers a comprehensive exploration of the potential hazards associated with the use of acetaminophen (also known as paracetamol) during pregnancy. It delves into the varying medical perspectives surrounding its use, examines the current regulatory framework and litigation against manufacturers and retailers of pharmaceutical products containing this ingredient.
Article information and share options
Acetaminophen (or paracetamol) is used to relieve mild to moderate pain and to reduce fever. It is an ingredient in more than 600 medications, including several very common and well known non-prescription consumer products.
Multiple studies have raised concerns about a possible link between acetaminophen use during pregnancy and autism/attention deficit hyperactivity disorder (ADHD) in children. However, many of these studies have been subject to criticism, and there is no clear consensus in the medical community on a link. Regulatory bodies have chosen not to impose any restrictions on acetaminophen or issue any additional recommendations against its use by pregnant women.
Read more about this trend spotlight by downloading the full version.